Discontinuation report ACT OLANZAPINE ODT

Last updated on 2020-01-24 History
Report ID 104277
Drug Identification Number 02327589
Brand name ACT OLANZAPINE ODT
Common or Proper name OLANZAPINE 15MG OD TABLETS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) OLANZAPINE
Strength(s) 15MG
Dosage form(s) TABLET (ORALLY DISINTEGRATING)
Route of administration ORAL
Packaging size 30UD
ATC code N05AH
ATC description ANTIPSYCHOTICS
Reason for discontinuation Business reasons
Anticipated discontinuation date
Actual discontinuation date 2019-12-05
Remaining supply date 2019-12-05
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-01-24 French Compare
v1 2020-01-24 English Compare